Completed

Ultrasound for Pneumothorax and Hemothorax in Critical Care

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being tested

Chest-Tube Insertion

Diagnostic Test
Who is being recruted

Hemorrhage+4

+ Hemothorax

+ Pathologic Processes

From 21 to 65 Years
+7 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Treatment Study

Interventional
Study Start: October 2023
See protocol details

Summary

Principal SponsorTanta University
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: October 1, 2023

Actual date on which the first participant was enrolled.

This study focuses on using ultrasound to diagnose and treat patients in critical care who have a collapsed lung (pneumothorax) or blood in the chest cavity (hemothorax). These conditions often result from injuries to the chest and can be dangerous if not treated quickly. Traditionally, doctors use chest tubes or special catheters to relieve these conditions. The study aims to standardize how ultrasound is used in these situations, as it can help healthcare professionals make quick decisions without moving patients, which can be risky. Participants in the study will have their conditions diagnosed and treated using ultrasound technology right at the bedside in the intensive care unit. This method allows doctors to see inside the body in real-time and guide the insertion of chest tubes or catheters safely. The goal is to improve the speed and safety of diagnosing and treating these serious conditions. By using ultrasound, the study seeks to reduce the potential complications that can arise from moving critically ill patients and improve the learning process for healthcare providers.

Official TitleInterprofessional Approach to Ultrasound Diagnosis and Intervention in Critical Care Patients With Pneumothorax and/or Hemothorax (Steering the Eagerness Towards Standardization of the Third Core Competency in ICU)
NCT06825299
Principal SponsorTanta University
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

50 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Treatment Study

These studies test new ways to treat a disease, condition, or health issue. The goal is to see if a new drug, therapy, or approach works better or has fewer side effects than existing options.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

From 21 to 65 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

HemorrhageHemothoraxPathologic ProcessesPleural DiseasesPneumothoraxRespiratory Tract DiseasesPathological Conditions, Signs and Symptoms

Criteria

3 inclusion criteria required to participate
Age from 21 to 65 years
Both sexes.
Patients with pneumothorax or hemothorax indicated for chest tube or pig tail insertion according to British Thoracic Society (BTS) June 2022 guidelines for pleural procedures.
4 exclusion criteria prevent from participating
Absolute contraindication: patients in which the lung is completely adherent to the chest wall throughout the hemithorax.
Relative contraindications: patients with risk of bleeding in patients:
Taking anticoagulant medication.
Patients with abnormal clotting profiles, coagulopathies, and platelet defects.

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

One single intervention group is designated in this study

This study does not include a placebo group 

Treatment Groups

Group I

Experimental
The Technique was performed according to combination of the BTS guidelines for chest tube insertion and US-guided technique for chest tube insertion by Dev et al. and Menegozzo et al. and US-guided pigtail insertion by Vetrugno et al

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Suspended

Tanta University

Tanta, EgyptOpen Tanta University in Google Maps
CompletedOne Study Center